BackgroundHealthcare-associated infective endocarditis (HCA-IE), a severe complication of
medical care, shows a growing incidence in literature.ObjectiveTo evaluate epidemiology, etiology, risk factors for acquisition, complications,
surgical treatment, and outcome of HCA-IE.MethodsObservational prospective case series study (2006-2011) in a public hospital in
Rio de Janeiro.ResultsFifty-three patients with HCA-IE from a total of 151 cases of infective
endocarditis (IE) were included. There were 26 (49%) males (mean age of 47
± 18.7 years), 27 (51%) females (mean age of 42 ± 20.1 years). IE
was acute in 37 (70%) cases and subacute in 16 (30%) cases. The mitral valve was
affected in 19 (36%) patients and the aortic valve in 12 (36%); prosthetic valves
were affected in 23 (43%) patients and native valves in 30 (57%). Deep intravenous
access was used in 43 (81%) cases. Negative blood cultures were observed in 11
(21%) patients, Enterococcus faecalis in 10 (19%),
Staphylococcus aureus in 9 (17%), and Candida sp. in 7 (13%).
Fever was present in 49 (92%) patients, splenomegaly in 12 (23%), new
regurgitation murmur in 31 (58%), and elevated C-reactive protein in 44/53 (83%).
Echocardiograms showed major criteria in 46 (87%) patients, and 34 (64%) patients
were submitted to cardiac surgery. Overall mortality was 17/53 (32%).ConclusionIn Brazil HCA-IE affected young subjects. Patients with prosthetic and native
valves were affected in a similar proportion, and non-cardiac surgery was an
infrequent predisposing factor, whereas intravenous access was a common one. S.
aureus was significantly frequent in native valve HCA-IE, and overall mortality
was high.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.